Structures and Biological Activities of Secondary Metabolites from IXylaria/I spp

The fungus genus Xylaria is an important source of drug discoveries in scientific fields and in the pharmaceutical industry due to its potential to produce a variety of structured novel and bioactive secondary metabolites. This review prioritizes the structures of the secondary metabolites of Xylari...

Full description

Saved in:
Bibliographic Details
Published in:Journal of fungi (Basel) 2024-02, Vol.10 (3)
Main Authors: Chen, Weikang, Yu, Miao, Chen, Shiji, Gong, Tianmi, Xie, Linlin, Liu, Jinqin, Bian, Chang, Huang, Guolei, Zheng, Caijuan
Format: Article
Language:English
Subjects:
Antifungal agents
Enzymes
Fungi
Lactones
Plant metabolites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue 3
container_start_page
container_title Journal of fungi (Basel)
container_volume 10
creator Chen, Weikang
Yu, Miao
Chen, Shiji
Gong, Tianmi
Xie, Linlin
Liu, Jinqin
Bian, Chang
Huang, Guolei
Zheng, Caijuan
description The fungus genus Xylaria is an important source of drug discoveries in scientific fields and in the pharmaceutical industry due to its potential to produce a variety of structured novel and bioactive secondary metabolites. This review prioritizes the structures of the secondary metabolites of Xylaria spp. from 1994 to January 2024 and their relevant biological activities. A total of 445 new compounds, including terpenoids, nitrogen-containing compounds, polyketides, lactones, and other classes, are presented in this review. Remarkably, among these compounds, 177 compounds show various biological activities, including cytotoxic, antimicrobial, anti-inflammatory, antifungal, immunosuppressive, and enzyme-inhibitory activities. This paper will guide further investigations into the structures of novel and potent active natural products derived from Xylaria and their potential contributions to the future development of new natural drug products in the agricultural and medicinal fields.
doi_str_mv 10.3390/jof10030190
format article
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A788249403</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A788249403</galeid><sourcerecordid>A788249403</sourcerecordid><originalsourceid>FETCH-LOGICAL-g673-b65895fd180ebfc332e28f5bc9f8034bf0ea997eb35e9282d360616f8ad30a573</originalsourceid><addsrcrecordid>eNptj81qwzAQhEVpoSHNqS8g6NnJWmvL0tEN_TGklJIccguyLBkF2wq2UsjbV9Aecih72GG-2YEl5DGFJaKE1dHbFAAhlXBDZgxBJhzE_vZK35PFNB0BIM0FlxJn5GsbxrMO59FMVA0NfXa-863TqqOlDu7bBReJt3RrtB8aNV7ohwmq9p0LEdjR97TaXzo1OrWq6HQ6PZA7q7rJLP72nOxeX3br92Tz-Vaty03S8gKTmudC5rZJBZjaakRmmLB5raUVgFltwSgpC1NjbiQTrEEOPOVWqAZB5QXOydNvbas6c3CD9WFUuneTPpSFECyTGWBMLf9JxWlM7-JDxrroXx38ACpqYQU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Structures and Biological Activities of Secondary Metabolites from IXylaria/I spp</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Chen, Weikang ; Yu, Miao ; Chen, Shiji ; Gong, Tianmi ; Xie, Linlin ; Liu, Jinqin ; Bian, Chang ; Huang, Guolei ; Zheng, Caijuan</creator><creatorcontrib>Chen, Weikang ; Yu, Miao ; Chen, Shiji ; Gong, Tianmi ; Xie, Linlin ; Liu, Jinqin ; Bian, Chang ; Huang, Guolei ; Zheng, Caijuan</creatorcontrib><description>The fungus genus Xylaria is an important source of drug discoveries in scientific fields and in the pharmaceutical industry due to its potential to produce a variety of structured novel and bioactive secondary metabolites. This review prioritizes the structures of the secondary metabolites of Xylaria spp. from 1994 to January 2024 and their relevant biological activities. A total of 445 new compounds, including terpenoids, nitrogen-containing compounds, polyketides, lactones, and other classes, are presented in this review. Remarkably, among these compounds, 177 compounds show various biological activities, including cytotoxic, antimicrobial, anti-inflammatory, antifungal, immunosuppressive, and enzyme-inhibitory activities. This paper will guide further investigations into the structures of novel and potent active natural products derived from Xylaria and their potential contributions to the future development of new natural drug products in the agricultural and medicinal fields.</description><identifier>ISSN: 2309-608X</identifier><identifier>EISSN: 2309-608X</identifier><identifier>DOI: 10.3390/jof10030190</identifier><language>eng</language><publisher>MDPI AG</publisher><subject>Antifungal agents ; Enzymes ; Fungi ; Lactones ; Plant metabolites</subject><ispartof>Journal of fungi (Basel), 2024-02, Vol.10 (3)</ispartof><rights>COPYRIGHT 2024 MDPI AG</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,786,790,27957,27958</link.rule.ids></links><search><creatorcontrib>Chen, Weikang</creatorcontrib><creatorcontrib>Yu, Miao</creatorcontrib><creatorcontrib>Chen, Shiji</creatorcontrib><creatorcontrib>Gong, Tianmi</creatorcontrib><creatorcontrib>Xie, Linlin</creatorcontrib><creatorcontrib>Liu, Jinqin</creatorcontrib><creatorcontrib>Bian, Chang</creatorcontrib><creatorcontrib>Huang, Guolei</creatorcontrib><creatorcontrib>Zheng, Caijuan</creatorcontrib><title>Structures and Biological Activities of Secondary Metabolites from IXylaria/I spp</title><title>Journal of fungi (Basel)</title><description>The fungus genus Xylaria is an important source of drug discoveries in scientific fields and in the pharmaceutical industry due to its potential to produce a variety of structured novel and bioactive secondary metabolites. This review prioritizes the structures of the secondary metabolites of Xylaria spp. from 1994 to January 2024 and their relevant biological activities. A total of 445 new compounds, including terpenoids, nitrogen-containing compounds, polyketides, lactones, and other classes, are presented in this review. Remarkably, among these compounds, 177 compounds show various biological activities, including cytotoxic, antimicrobial, anti-inflammatory, antifungal, immunosuppressive, and enzyme-inhibitory activities. This paper will guide further investigations into the structures of novel and potent active natural products derived from Xylaria and their potential contributions to the future development of new natural drug products in the agricultural and medicinal fields.</description><subject>Antifungal agents</subject><subject>Enzymes</subject><subject>Fungi</subject><subject>Lactones</subject><subject>Plant metabolites</subject><issn>2309-608X</issn><issn>2309-608X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNptj81qwzAQhEVpoSHNqS8g6NnJWmvL0tEN_TGklJIccguyLBkF2wq2UsjbV9Aecih72GG-2YEl5DGFJaKE1dHbFAAhlXBDZgxBJhzE_vZK35PFNB0BIM0FlxJn5GsbxrMO59FMVA0NfXa-863TqqOlDu7bBReJt3RrtB8aNV7ohwmq9p0LEdjR97TaXzo1OrWq6HQ6PZA7q7rJLP72nOxeX3br92Tz-Vaty03S8gKTmudC5rZJBZjaakRmmLB5raUVgFltwSgpC1NjbiQTrEEOPOVWqAZB5QXOydNvbas6c3CD9WFUuneTPpSFECyTGWBMLf9JxWlM7-JDxrroXx38ACpqYQU</recordid><startdate>20240201</startdate><enddate>20240201</enddate><creator>Chen, Weikang</creator><creator>Yu, Miao</creator><creator>Chen, Shiji</creator><creator>Gong, Tianmi</creator><creator>Xie, Linlin</creator><creator>Liu, Jinqin</creator><creator>Bian, Chang</creator><creator>Huang, Guolei</creator><creator>Zheng, Caijuan</creator><general>MDPI AG</general><scope/></search><sort><creationdate>20240201</creationdate><title>Structures and Biological Activities of Secondary Metabolites from IXylaria/I spp</title><author>Chen, Weikang ; Yu, Miao ; Chen, Shiji ; Gong, Tianmi ; Xie, Linlin ; Liu, Jinqin ; Bian, Chang ; Huang, Guolei ; Zheng, Caijuan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g673-b65895fd180ebfc332e28f5bc9f8034bf0ea997eb35e9282d360616f8ad30a573</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Antifungal agents</topic><topic>Enzymes</topic><topic>Fungi</topic><topic>Lactones</topic><topic>Plant metabolites</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Weikang</creatorcontrib><creatorcontrib>Yu, Miao</creatorcontrib><creatorcontrib>Chen, Shiji</creatorcontrib><creatorcontrib>Gong, Tianmi</creatorcontrib><creatorcontrib>Xie, Linlin</creatorcontrib><creatorcontrib>Liu, Jinqin</creatorcontrib><creatorcontrib>Bian, Chang</creatorcontrib><creatorcontrib>Huang, Guolei</creatorcontrib><creatorcontrib>Zheng, Caijuan</creatorcontrib><jtitle>Journal of fungi (Basel)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Weikang</au><au>Yu, Miao</au><au>Chen, Shiji</au><au>Gong, Tianmi</au><au>Xie, Linlin</au><au>Liu, Jinqin</au><au>Bian, Chang</au><au>Huang, Guolei</au><au>Zheng, Caijuan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Structures and Biological Activities of Secondary Metabolites from IXylaria/I spp</atitle><jtitle>Journal of fungi (Basel)</jtitle><date>2024-02-01</date><risdate>2024</risdate><volume>10</volume><issue>3</issue><issn>2309-608X</issn><eissn>2309-608X</eissn><abstract>The fungus genus Xylaria is an important source of drug discoveries in scientific fields and in the pharmaceutical industry due to its potential to produce a variety of structured novel and bioactive secondary metabolites. This review prioritizes the structures of the secondary metabolites of Xylaria spp. from 1994 to January 2024 and their relevant biological activities. A total of 445 new compounds, including terpenoids, nitrogen-containing compounds, polyketides, lactones, and other classes, are presented in this review. Remarkably, among these compounds, 177 compounds show various biological activities, including cytotoxic, antimicrobial, anti-inflammatory, antifungal, immunosuppressive, and enzyme-inhibitory activities. This paper will guide further investigations into the structures of novel and potent active natural products derived from Xylaria and their potential contributions to the future development of new natural drug products in the agricultural and medicinal fields.</abstract><pub>MDPI AG</pub><doi>10.3390/jof10030190</doi></addata></record>
fulltext fulltext
identifier ISSN: 2309-608X
ispartof Journal of fungi (Basel), 2024-02, Vol.10 (3)
issn 2309-608X
2309-608X
language eng
recordid cdi_gale_infotracmisc_A788249403
source Publicly Available Content Database; PubMed Central
subjects Antifungal agents
Enzymes
Fungi
Lactones
Plant metabolites
title Structures and Biological Activities of Secondary Metabolites from IXylaria/I spp
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-22T22%3A37%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Structures%20and%20Biological%20Activities%20of%20Secondary%20Metabolites%20from%20IXylaria/I%20spp&rft.jtitle=Journal%20of%20fungi%20(Basel)&rft.au=Chen,%20Weikang&rft.date=2024-02-01&rft.volume=10&rft.issue=3&rft.issn=2309-608X&rft.eissn=2309-608X&rft_id=info:doi/10.3390/jof10030190&rft_dat=%3Cgale%3EA788249403%3C/gale%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-g673-b65895fd180ebfc332e28f5bc9f8034bf0ea997eb35e9282d360616f8ad30a573%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A788249403&rfr_iscdi=true